KIMMTRAK 100 micrograms/0.5 mL concentrate for solution for infusion
EORTC 2022-MG
Phase 3 small_molecule active
Quick answer
KIMMTRAK 100 micrograms/0.5 mL concentrate for solution for infusion for Uveal Melanoma is a Phase 3 program (small_molecule) at Cancer Prevention Pharma (Ireland) Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cancer Prevention Pharma (Ireland) Limited
- Indication
- Uveal Melanoma
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active